CN102657688A - Traditional Chinese medicine composition capable of preventing cardiovascular and cerebrovascular diseases and application thereof - Google Patents
Traditional Chinese medicine composition capable of preventing cardiovascular and cerebrovascular diseases and application thereof Download PDFInfo
- Publication number
- CN102657688A CN102657688A CN2012101838619A CN201210183861A CN102657688A CN 102657688 A CN102657688 A CN 102657688A CN 2012101838619 A CN2012101838619 A CN 2012101838619A CN 201210183861 A CN201210183861 A CN 201210183861A CN 102657688 A CN102657688 A CN 102657688A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- medicine composition
- cardiovascular
- traditional chinese
- application
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention discloses a traditional Chinese medicine composition capable of preventing cardiovascular and cerebrovascular diseases and an application thereof. The traditional Chinese medicine composition is prepared from the following raw materials in parts by weight: 20-40 parts of American ginseng, 20-40 parts of panax notoginseng and 20-40 parts of hippocampus japonicus. For the traditional Chinese medicine composition, after active ingredients are extracted in proportion, the active ingredients can be prepared into tablets, capsules, dissolved medicines, oral liquid or pills for taking; the traditional Chinese medicine composition is applied in the preparation of products for preventing cardiovascular and cerebrovascular diseases; and after long-term taking, the traditional Chinese medicine composition can be used for effectively reducing blood pressure, adjusting the blood consistency and reducing the blood coagulability so as to reduce the incidence of cardiovascular and cerebrovascular diseases and protect cardiovascular and cerebrovascular systems of middle-aged and aged people, thus having important positive significance in promoting the health of middle-aged and aged people.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition and application thereof that can prevent cardiovascular and cerebrovascular disease.
Background technology
Cardiovascular and cerebrovascular disease is that a kind of serious threat is human, the healthy commonly encountered diseases of middle-aged and elderly people more than 50 years old particularly, and every year is died from the number of cardiovascular and cerebrovascular disease up to 1,500 ten thousand people in the whole world, and it is the first to occupy the various causes of the death.Cardiovascular and cerebrovascular disease has become the highest No.1 killer of the human dead cause of disease, also is " the noiseless demon " of health of people.Cardiovascular and cerebrovascular disease has " sickness rate is high, disability rate is high, mortality rate is high, relapse rate is high, and complication is how " i.e. characteristics of " four is high by more than ", and at present, China cardiovascular and cerebrovascular disease patient has surpassed 2.7 hundred million people! China dies from nearly 3,000,000 people of cardiovascular and cerebrovascular disease every year, accounts for 51% of the annual total dead cause of disease of China.The morbidity principal element of cardiovascular and cerebrovascular disease is hyperlipidemia and hypertension; Blood viscosity raises rapidly during hyperlipidemia; Untimely prevention, conditioning causes cerebral ischemia, if will cause cardiovascular and cerebrovascular diseases such as coronary heart disease, hypertension, cerebral thrombosis, fatty liver; Hypertension-induced cerebral hemorrhage and cerebral thrombosis, thus cardiovascular and cerebrovascular disease caused.Have only and fundamentally root out the factor of bringing out cardiovascular and cerebrovascular disease, could effectively reduce the sickness rate of old people's cardiovascular and cerebrovascular disease, present existing blood pressure lowering and the method that reduces hyperlipidemia; General main through regulating dietary habit; Reduce the intake of sugar and fat, can also take a certain amount of aspirin medicine etc. in addition, because the raising of quality of life; Be difficult to quantitatively control sugar and fatty absorption in the diet, this has increased difficulty all for the prevention of cardiovascular and cerebrovascular disease.
Summary of the invention
The object of the present invention is to provide a kind of Chinese medicine composition and application thereof that can prevent cardiovascular and cerebrovascular disease, it has blood pressure lowering, regulates haemoconcentration, reduces the effect of cardiovascular and cerebrovascular disease predisposing factors.
The present invention realizes that so a kind of Chinese medicine composition and application thereof that can prevent cardiovascular and cerebrovascular disease is characterized in that said Chinese medicine composition is made up of the raw material of following parts by weight: Radix Panacis Quinquefolii 20-40 part, Radix Notoginseng 20-40 part and Hippocampus 20-40 part; Said Chinese medicine composition by said ratio extraction effective ingredient after, take after processing tablet, capsule, electuary, oral liquid or pill to effective ingredient; Said Chinese medicine composition is used for preparing the application of prevention cardiovascular and cerebrovascular disease product.
Technique effect of the present invention is: the present invention takes for a long time, can effectively bring high blood pressure down, and regulates the blood denseness; Reduce blood coagulation property; Reduce the cardiovascular and cerebrovascular disease sickness rate, protection middle-aged and elderly people cardio-cerebrovascular promotes middle-aged and elderly people health to have important positive effect.
The specific embodiment
Below in conjunction with embodiment the present invention is done further elaboration,
The present invention realizes like this, a kind of Chinese medicine composition and application thereof that can prevent cardiovascular and cerebrovascular disease, and said Chinese medicine composition is made up of the raw material of following parts by weight: Radix Panacis Quinquefolii 20-40 part, Radix Notoginseng 20-40 part and Hippocampus 20-40 part; Said Chinese medicine composition by said ratio extraction effective ingredient after, take after processing tablet, capsule, electuary, oral liquid or pill to effective ingredient; Said Chinese medicine composition is used for preparing the application of prevention cardiovascular and cerebrovascular disease product.Radix Panacis Quinquefolii has ginsenoside's composition, and it has the blood coagulation property of reduction, suppresses platelet aggregation, atherosclerosis and promotes the erythrocyte growth, increases hematochrome; The effect of strengthening body resistance; Take Radix Panacis Quinquefolii for a long time, can effectively strengthen myocardial contraction, it is active to improve blood.Radix Notoginseng has reasonable cholesterol reducing; The effect of triglyceride reducing; Radix Notoginseng can effectively reduce the viscosity of blood; Hippocampus is rich in the multiple proteins and the aminoacid of AChE, cholinesterase and needed by human, and Hippocampus has the effect of building body, especially nerve system of human body is had important function.
Embodiment one
Get Radix Panacis Quinquefolii 2 grams, Radix Notoginseng 2 grams, Hippocampus 4 grams, extract effective ingredient, and process pill to effective ingredient, press metering with water delivery service 3 grams; Three times on the one, took clinical trial 189 routine hypertension symptom persons 30 days; Wherein 175 routine blood are normal, and 14 routine blood pressures obviously do not reduce, effective percentage 92.6%.
Embodiment two
Get Radix Panacis Quinquefolii 10 grams, Radix Notoginseng 10 grams, Hippocampus 10 grams, extract effective ingredient, and process electuary to effective ingredient;, one day twice, took 60 days with water delivery service 5 grams by metering; Clinical trial 352 routine Blood Ropy disease symptoms; Wherein 346 routine blood viscositys obviously reduce, and 6 routine blood viscositys do not have obvious reduction, effective percentage 98.3%.
Embodiment three
Get Radix Panacis Quinquefolii 40 grams, Radix Notoginseng 40 grams, Hippocampus 20 grams, extract effective ingredient, and process pill to effective ingredient, press metering with water delivery service 3 grams; Three times on the one, took clinical trial 171 routine hypertension symptom persons 15 days; Wherein 159 routine blood are normal, and 14 routine blood pressures obviously do not reduce, effective percentage 93%.
Claims (3)
1. the Chinese medicine composition and application thereof that can prevent cardiovascular and cerebrovascular disease is characterized in that said Chinese medicine composition is made up of the raw material of following parts by weight: Radix Panacis Quinquefolii 20-40 part, Radix Notoginseng 20-40 part and Hippocampus 20-40 part.
2. a kind of Chinese medicine composition and application thereof that can prevent cardiovascular and cerebrovascular disease as claimed in claim 1; It is characterized in that; Said Chinese medicine composition by said ratio extraction effective ingredient after, take after processing tablet, capsule, electuary, oral liquid or pill to effective ingredient.
3. according to claim 1 or claim 2 a kind of Chinese medicine composition and application thereof that can prevent cardiovascular and cerebrovascular disease is characterized in that, said Chinese medicine composition is used for preparing the application of prevention cardiovascular and cerebrovascular disease product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012101838619A CN102657688A (en) | 2012-06-06 | 2012-06-06 | Traditional Chinese medicine composition capable of preventing cardiovascular and cerebrovascular diseases and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012101838619A CN102657688A (en) | 2012-06-06 | 2012-06-06 | Traditional Chinese medicine composition capable of preventing cardiovascular and cerebrovascular diseases and application thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102657688A true CN102657688A (en) | 2012-09-12 |
Family
ID=46767356
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012101838619A Pending CN102657688A (en) | 2012-06-06 | 2012-06-06 | Traditional Chinese medicine composition capable of preventing cardiovascular and cerebrovascular diseases and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102657688A (en) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1463718A (en) * | 2002-06-16 | 2003-12-31 | 向许佑 | A process of preparing medicine for treating cardiac cerebral arteriosclerosis |
| CN101129469A (en) * | 2007-03-05 | 2008-02-27 | 厦门金日制药有限公司 | Traditional Chinese medicine composition for preventing and controlling cardiovascular disease |
| CN101569672A (en) * | 2008-04-29 | 2009-11-04 | 潘诚 | Golden brain powder |
| KR20110092721A (en) * | 2010-02-10 | 2011-08-18 | 대구산업정보대학 산학협력단 | The composite make natural korean herb cosmetics from genseng saponin rg1 and polia coccos ferment |
| CN102258686A (en) * | 2011-07-08 | 2011-11-30 | 杨怀喜 | Chinese medicinal preparation for preventing and treating cardiovascular and cerebrovascular diseases |
| CN102475740A (en) * | 2010-11-21 | 2012-05-30 | 邹长根 | American ginseng refreshment preparation and its preparation method |
-
2012
- 2012-06-06 CN CN2012101838619A patent/CN102657688A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1463718A (en) * | 2002-06-16 | 2003-12-31 | 向许佑 | A process of preparing medicine for treating cardiac cerebral arteriosclerosis |
| CN101129469A (en) * | 2007-03-05 | 2008-02-27 | 厦门金日制药有限公司 | Traditional Chinese medicine composition for preventing and controlling cardiovascular disease |
| CN101569672A (en) * | 2008-04-29 | 2009-11-04 | 潘诚 | Golden brain powder |
| KR20110092721A (en) * | 2010-02-10 | 2011-08-18 | 대구산업정보대학 산학협력단 | The composite make natural korean herb cosmetics from genseng saponin rg1 and polia coccos ferment |
| CN102475740A (en) * | 2010-11-21 | 2012-05-30 | 邹长根 | American ginseng refreshment preparation and its preparation method |
| CN102258686A (en) * | 2011-07-08 | 2011-11-30 | 杨怀喜 | Chinese medicinal preparation for preventing and treating cardiovascular and cerebrovascular diseases |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103341052A (en) | Medicine for preventing and treating hypertension, hyperlipidemia, hyperglycemia and hypotension and preparation method thereof | |
| CA2801099C (en) | Use of a chinese medicine composition in preparing medicaments for treating secondary prevention of myocardial infarction | |
| NO335203B1 (en) | Treatment of aspirin resistance with radix sage miltiorrhiaze, its extract and composition. | |
| CN104825788B (en) | Application of traditional Chinese medicine composition in preparation of medicine for treating transient ischemic attack | |
| CN103479691B (en) | Fat-reducing liver-protecting Chinese medicine composition | |
| CN104857154A (en) | Traditional Chinese medicine composition for treating three-high diseases and preparation method therefor | |
| CN107441329A (en) | A kind of Chinese medicinal formulae nursed one's health for diabetes and Sjogren syndrome | |
| CN1733031A (en) | Brain caring oral liquid and its preparation process | |
| CN105361171B (en) | One kind having composition for relieving physical fatigue | |
| CN101697989B (en) | Application of notoginseng and extract thereof in preparing medicaments for treating and/or preventing coronary artherosclerosis | |
| CN101249207A (en) | Medicament prescription for treating coronary heart disease | |
| CN102657688A (en) | Traditional Chinese medicine composition capable of preventing cardiovascular and cerebrovascular diseases and application thereof | |
| CN104547026B (en) | Preparation method and application of salvia miltiorrhiza leave pseudo-ginseng extract | |
| CN104547027B (en) | Preparation method and application of salvia miltiorrhiza leave and panax notoginseng leaf extract | |
| CN105617069B (en) | Oral liquid for regulating bipolar affective disorder and preparation method thereof | |
| CN102961523A (en) | Traditional Chinese medicine for treating hyperlipidemia and arteriosclerosis | |
| CN102068621B (en) | Chinese medicinal composition for treating infantile cold and fever and preparation method thereof | |
| CN102266540B (en) | Chinese medicament for treating constipation | |
| CN102225082A (en) | Medicament for preventing and treating diabetes and complications thereof and preparation method thereof | |
| CN103505507A (en) | Traditional Chinese medicine composition containing glossy ganoderma and preparation method of composition | |
| CN1255149C (en) | Combination of medication | |
| CN105596663A (en) | Weight-losing drug | |
| CN104547025B (en) | Salvia miltiorrhiza and pseudo-ginseng leaf extract and preparation method thereof | |
| CN1110176A (en) | Oral drug for curing diabetes and complicated angiocardiopathy | |
| CN103800406A (en) | Compound organic zinc preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20120912 |